Skip to main content
. 2016 May 23;66(9):1573–1583. doi: 10.1136/gutjnl-2015-310705

Table 1.

Patient characteristics

  Discovery cohort
Validation cohort
Control CD UC Control CD UC
Patients, n (m/f) 20 (10/10) 15 (10/5) 15 (7/8) 19 (9/10) 15 (10/5) 15 (6/9)
Age, y* 15.5 (11.6–16.6) 13.9 (10.8–16.6) 14.8 (13.3–16.3) 15.3 (12.8–16.5) 14.1 (10.8–15.6) 13.7 (11.1–16.5)
PCDAI/PUCAI* NA 37.5 (32.5–57.5) 45.0 (30.0–70.0) NA 47.5 (32.5–57.5) 50.0 (40.0–70.0)
Classification
 A1a 3   2
 A1b 12   13
 L1 3   0
 L2 2   2
 L3 10   13
 L4a 4   9
 L4b 1   2
 B1 15   15
 B2 0   0
 P 4   2
 G0 12   13
 G1 3   2
 E1   0   0
 E2   1   1
 E3   1   1
 E4   13   13
 S0   10   10
 S1   5   5

*Values shown as median (IQR).

CD, Crohn's disease; NA, not applicable; PCDAI, Pediatric Crohn's Disease Activity Index; PUCAI, Pediatric UC Activity Index.